Flunarizine

Flunarizine

SCHEMBL43440

Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 1.00
CYP2D6 P10635 5/20 1.00
MEN1 O00255 4/20 1.00
KMT2A Q03164 4/20 1.00
HIF1A Q16665 4/20 1.00
OPRM1 P35372 4/20 1.00
MAPT P10636 4/20 1.00
CYP3A4 P08684 4/20 1.00
CYP1A2 P05177 4/20 1.00
CYP2C9 P11712 4/20 1.00
MAPK1 P28482 4/20 1.00
SIGMAR1 Q99720 3/20 1.00
SLC6A4 P31645 3/20 1.00
SLC6A3 Q01959 3/20 1.00
CHRM2 P08172 2/20 1.00
CHRM4 P08173 2/20 1.00
HTR1A P08908 2/20 1.00
CHRM5 P08912 2/20 1.00
ADRA2A P08913 2/20 1.00
ADORA3 P0DMS8 2/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Flunarizine SCHEMBL16225927 1.00 LMNA (1.00) LMNACYP2D6MEN1KMT2AHIF1A
Flunarizine SCHEMBL43441 1.00 LMNA (1.00) LMNACYP2D6MEN1KMT2AHIF1A
Flunarizine SCHEMBL16226917 0.99 LMNA (1.00) LMNACYP2D6MEN1KMT2AHIF1A
Flunarizine SCHEMBL1321708 0.99 LMNA (1.00) LMNACYP2D6MEN1KMT2AHIF1A
Flunarizine SCHEMBL10993579 0.99 LMNA (0.97) LMNACYP2D6MEN1KMT2AHIF1A
Flunarizine SCHEMBL120168 0.99 LMNA (1.00) LMNACYP2D6MEN1KMT2AHIF1A
Flunarizine SCHEMBL120169 0.99 LMNA (1.00) LMNACYP2D6MEN1KMT2AHIF1A
SCHEMBL2615163 0.99 LMNA (0.97) LMNACYP2D6MEN1KMT2AHIF1A
SCHEMBL2615158 0.99 LMNA (0.97) LMNACYP2D6MEN1KMT2AHIF1A
Flunarizine SCHEMBL27766230 0.99 LMNA (0.97) LMNACYP2D6MEN1KMT2AHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 12573 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4741492-A2 NECROSIS INHIBITOR Linkgevity Limited (GB) 2026-05-13 EP claimed
EP-4255391-B1 LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION METRIOPHARM AG (CH) 2026-05-06 EP claimed
EP-4704971-A1 GAMMA STIMULATION AND NEUROMODULATOR COMBINATION THERAPY Cognito Therapeutics, Inc. (US) 2026-03-11 EP claimed
US-12550885-B2 Red blood cell storage solutions, solution additives, and methods for improving the storage of red blood cells UNIVERSITY OF CINCINNATI (US) 2026-02-17 US claimed
EP-4691483-A2 TREATING REFRACTORY MIGRAINE Teva Pharmaceuticals International GmbH (CH) 2026-02-11 EP claimed
US-20260001942-A1 TREATMENT OF HEADACHE DISORDERS AND/OR PSYCHIATRIC SYMPTOMS USING ANTI-CGRP ANTIBODIES, AND COMPOSITIONS AND METHODS RELATED THERETO H LUNDBECK AS (DK) 2026-01-01 US claimed
WO-2025262247-A1 TREATMENT OF HEADACHE DISORDERS AND/OR PSYCHIATRIC SYMPTOMS USING ANTI-CGRP ANTIBODIES, AND COMPOSITIONS AND METHODS RELATED THERETO H. LUNDBECK A/S (DK) 2025-12-26 WO claimed
EP-3515937-B1 TREATING REFRACTORY MIGRAINE TEVA PHARMACEUTICALS INT GMBH (CH) 2025-12-17 EP claimed
EP-4658278-A1 SELECTIVE FIASMA TREATMENT Valo Health, Inc. (US) 2025-12-10 EP claimed
EP-4655068-A1 MIGRAINE THERAPY MedImmune Limited (GB) 2025-12-03 EP claimed
EP-0100037-B1 MEDICAMENT FOR TREATING SLEEP DISORDERS Merckle GmbH (DE) 1987-01-21 EP claimed
US-4618598-A Method of regulating hormone function or release DUKE UNIVERSITY (US) 1986-10-21 US claimed
EP-0197571-A2 Novel derivatives of gamma-cyclodextrin JANSSEN PHARMACEUTICA N.V. (BE) 1986-10-15 EP claimed
US-4612194-A VITAMIN E, VASODILATORS ROSHDY ISMAIL 1986-09-16 US claimed
US-4584294-A Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents MERCK & CO., INC. (US) 1986-04-22 US claimed
EP-0166353-A2 Benzofused lactams useful as antihypertensive agents and as cholecystokinin antagonists MERCK & CO. INC. (US) 1986-01-02 EP claimed
EP-0163237-A2 Di- and tri-peptidal renin inhibitors MERCK & CO. INC. (US) 1985-12-04 EP claimed
WO-1985002767-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING DRUGS WHICH ARE INSTABLE OR SPARINGLY SOLUBLE IN WATER AND METHODS FOR THEIR PREPARATION JANSSEN PHARMACEUTICA N.V. (BE) 1985-07-04 WO claimed
US-4505914-A BARBITURATES PLUS CINNARIZINE OR FLUNARIZINE MERCKLE GMBH (DE) 1985-03-19 US claimed
EP-0129189-A2 Renin inhibitors containing a C-terminal amide cycle and compositions and combinations containing the same MERCK & CO. INC. (US) 1984-12-27 EP claimed